| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/15/2011 | CN101402986B Method for producing collagen, glutin or collagen by degreasing and deliming of fish scale |
| 06/15/2011 | CN101294188B Lactoferrin antimicrobial peptide, preparing method and uses thereof |
| 06/15/2011 | CN101113422B Bacillus licheniformis fibrinolytic enzyme and production method thereof |
| 06/15/2011 | CN101010338B Muteins of fibroblast growth factor 21 |
| 06/14/2011 | US7960535 Recombinant lipidated PsaA protein, methods of preparation and use |
| 06/14/2011 | US7960534 Thermophilic and thermoacidophilic sugar transporter genes and enzymes from alicyclobacillus acidocaldarius and related organisms, methods |
| 06/14/2011 | US7960533 Nucleic acids coding for adhesion factor of group B Streptococcus, adhesion factors of group B Streptococcus and further uses thereof |
| 06/14/2011 | US7960531 EG-VEGF nucleic acids and polypeptides and methods of use |
| 06/14/2011 | US7960530 Fluorescent protein |
| 06/14/2011 | US7960524 polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems having greater flexibility for commercial use; for the production of bioactive molecules of interest |
| 06/14/2011 | US7960518 Human binding molecules having killing activity against enterococci and uses thereof |
| 06/14/2011 | US7960517 Methods for antibody engineering |
| 06/14/2011 | US7960516 Solid forms of anti-EGFR antibodies |
| 06/14/2011 | US7960514 IL-7 fusion proteins |
| 06/14/2011 | US7960512 Identification and engineering of antibodies with variant Fc regions and methods of using same |
| 06/14/2011 | US7960311 Methods employing combinatorial artificial receptors |
| 06/14/2011 | US7960175 Process for producing human-origin immunocompetent cell |
| 06/14/2011 | US7960163 Matriptase, a serine protease and its applications |
| 06/14/2011 | US7960156 Glucose dehydrogenase and method for producing the dehydrogenase |
| 06/14/2011 | US7960155 Cytochrome p450 monooxygenases and their use for oxidizing organic compounds |
| 06/14/2011 | US7960145 Compositions and methods for generating antibodies |
| 06/14/2011 | US7960144 Circular permutant GFP insertion folding reporters |
| 06/14/2011 | US7960143 Method for simultaneous production of multiple proteins; vectors and cells for use therein |
| 06/14/2011 | US7960142 Stabilized polypeptide compositions |
| 06/14/2011 | US7960140 Avidin mutants |
| 06/14/2011 | US7960137 Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter |
| 06/14/2011 | US7960128 TRP8, a transient receptor potential channel expressed in taste receptor cells |
| 06/14/2011 | US7960127 Using channel protein to identify inhibitors of bitter and/or sweet taste preception |
| 06/14/2011 | US7959933 Activatable recombinant neurotoxins |
| 06/14/2011 | US7959930 Rescue of influenza virus |
| 06/14/2011 | US7959926 Using hydrophobic interaction chromatography (HIC) matrix to recover somatotropins |
| 06/14/2011 | US7959925 Trimeric OX40-immunoglobulin fusion protein and methods of use |
| 06/14/2011 | US7959924 Gastric inhibitory polypeptide (GIP) antigen arrays and uses thereof |
| 06/14/2011 | US7959923 Method for treating cancer using anti-Wnt2 monoclonal antibodies and siRNA |
| 06/14/2011 | US7959910 C-terminally truncated interferon alpha variants |
| 06/14/2011 | CA2494241C Botulinum toxin pharmaceutical compositions |
| 06/14/2011 | CA2413546C Modification of hepatitis b core antigen |
| 06/14/2011 | CA2369622C Novel method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-egp-2 scfv fragment |
| 06/14/2011 | CA2359705C Chromatographic process for purification of albumin |
| 06/14/2011 | CA2324853C Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 06/14/2011 | CA2293829C Methods and compositions for galactosylated glycoproteins |
| 06/14/2011 | CA2182621C Galanin receptor, nucleic acids, transformed cells and uses thereof |
| 06/14/2011 | CA2178212C Monoclonal antibodies specific for phf-tau, hybridomas secreting them, antigen recognition by these antibodies and their applications |
| 06/09/2011 | WO2011069104A2 Multispecific antibodies, antibody analogs, compositions, and methods |
| 06/09/2011 | WO2011068758A1 Improved methods and compositions for detecting and treating cea-expressing cancers |
| 06/09/2011 | WO2011068165A1 Identification and inhibition of plant-derived sugar-chain-added enzyme gene |
| 06/09/2011 | WO2011019827A9 Phage displaying system expressing single chain antibody |
| 06/09/2011 | WO2003043587A9 Recovery of recombinant human parainfluenza virus type 1 (hpiv1) from cdna |
| 06/09/2011 | US20110138489 Transgenic animals expressing chimeric antibodies for use in preparing human antibodies |
| 06/09/2011 | US20110137014 Super humanized antibodies |
| 06/09/2011 | US20110137013 Novel collagen-like protein clac, precursor thereof and genes encoding the same |
| 06/09/2011 | US20110137012 Cell culture method using amino acid-enriched medium |
| 06/09/2011 | US20110137011 Hyperglycosylated human coagulation factor ix |
| 06/09/2011 | US20110136896 Variant hcmv pp65, ie1, and ie2 polynucleotides and uses thereof |
| 06/09/2011 | US20110136746 Kallikrein-Binding "Kunitz Domain" Proteins and Analogues Thereof |
| 06/09/2011 | US20110136743 Survivin, a protein that inhibits cellular apoptosis, and its modulation |
| 06/09/2011 | US20110136682 Antennary fucosylation in glycoproteins from cho cells |
| 06/09/2011 | US20110136224 Mda-7 proteins and methods of use thereof |
| 06/09/2011 | US20110136204 Extract of e. coli cells having mutation in ribosomal protein s12, and method for producing protein in cell-free system using the extract |
| 06/09/2011 | US20110136174 Method for producing cellulolytic enzyme using clostridium microorganism and method for culturing and proliferating clostridium microorganism |
| 06/09/2011 | US20110136173 Novel Method for the Stabilization of Chimeric Immunoglobulins or Immunoglobulin Fragments, and Stabilized Anti-EGP-2 SCFV Fragment |
| 06/09/2011 | US20110136172 Mammalian cytokines; related reagents |
| 06/09/2011 | US20110136171 Improved protein expression system |
| 06/09/2011 | US20110136170 Method and kit for purification of recombinant proteins using a self-cleaving protein intein |
| 06/09/2011 | US20110136169 Expression system compositions and methods |
| 06/09/2011 | US20110136168 Process for production of non-natural protein having ester bond therein |
| 06/09/2011 | US20110135718 Viral particle-like structure in physiological conditions, and method of forming it |
| 06/09/2011 | US20110135687 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 06/09/2011 | US20110135662 FUNCTION MODIFYING NAv 1.7 ANTIBODIES |
| 06/09/2011 | US20110135657 Human antigen binding proteins that bind beta-klotho, fgf receptors and complexes thereof |
| 06/09/2011 | US20110135653 Antibodies Against HER2 Truncated Variant CTF-611 |
| 06/09/2011 | US20110135647 Genes and polypeptides relating to breast cancers |
| 06/09/2011 | US20110135630 Chemical modification of antibody fragments |
| 06/09/2011 | US20110135596 Fusion protein comprising ubiquitin or ubiquitin-like protein, membrane translocation sequence and biologically active molecule and use thereof |
| 06/09/2011 | CA2782330A1 Improved methods and compositions for detecting and treating cea-expressing cancers |
| 06/09/2011 | CA2781682A1 Multispecific antibodies, antibody analogs, compositions, and methods |
| 06/08/2011 | EP2330213A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 06/08/2011 | EP2330205A1 Plant cells expressing human glucocerebrosidase |
| 06/08/2011 | EP2330204A1 Production of iduronate-2-sulphatase in plant culture |
| 06/08/2011 | EP2330201A1 Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy |
| 06/08/2011 | EP2330198A1 IL-1 related polypeptides |
| 06/08/2011 | EP2330197A2 Antagonistic selective binding agents of osteoprotegerin binding protein |
| 06/08/2011 | EP2330189A1 Method for large scale production of virus |
| 06/08/2011 | EP2330185A1 Method for producing cellulolytic enzyme using clostridium microorganism and method for culturing and proliferating clostridium microorganism |
| 06/08/2011 | EP2330129A2 Anti-TNF antibodies, compositions, methods and uses |
| 06/08/2011 | EP2330128A1 Modified anti-heparin/pf4 complex antibody and hit antibody standard |
| 06/08/2011 | EP2330127A2 Kallikrein-inhibiting Kunitz Domain proteins and nucleic acids encoding the same |
| 06/08/2011 | EP2329814A1 Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer |
| 06/08/2011 | EP2021357B1 Cyclodipeptide synthetases and their use for synthesis of cyclo(leu-leu) cyclodipeptide |
| 06/08/2011 | EP1817584B1 Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (pth) 1-84 |
| 06/08/2011 | EP1791961B1 Protein production method utilizing yebf |
| 06/08/2011 | EP1707629B1 Expression system using mammalian beta-actin promoter |
| 06/08/2011 | EP1069185B1 Humanized antibody against human tissue factor (tf) and process for constructing humanized antibody |
| 06/08/2011 | EP0960936B1 Reconstituted human anti-hm1.24 antibody |
| 06/08/2011 | CN1852736B Immunoglobulin chimeric monomer-dimer hybrids |
| 06/08/2011 | CN102089438A Method of producing clostridium botulinum toxin using media containing plant-derived components and flexible closed container |
| 06/08/2011 | CN102089432A Soluble recombinant influenza antigens |
| 06/08/2011 | CN102089423A Enhancement of transgene expression from viral-based vaccine vecors by expression of suppressors of the type i interferon response |
| 06/08/2011 | CN102089326A Anti-IL-6/IL-6R antibodies and methods of use thereof |
| 06/08/2011 | CN102089004A Pharmaceutical composition for treatment and prevention of cancer |